e-learning
resources
Vienna 2012
Tuesday, 04.09.2012
Fibrogenesis between epithelial injury and fibroblast proliferation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Rikkunshito ameliorates bleomycin-induced lung injury in mice
H. Tsubouchi, S. Yanagi, S. Iizuka, S. Mogami, K. Miyoshi, N. Matsumoto, M. Nakazato (Ibaraki, Japan)
Source:
Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation
Session:
Fibrogenesis between epithelial injury and fibroblast proliferation
Session type:
Thematic Poster Session
Number:
3754
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Tsubouchi, S. Yanagi, S. Iizuka, S. Mogami, K. Miyoshi, N. Matsumoto, M. Nakazato (Ibaraki, Japan). Rikkunshito ameliorates bleomycin-induced lung injury in mice. Eur Respir J 2012; 40: Suppl. 56, 3754
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Lane-hamilton syndrome and CCF: a fatal association
Related content which might interest you:
Ghrelin protects against bleomycin-induced pulmonary fibrosis in mice
Source: International Congress 2017 – Lung fibrosis: basic science
Year: 2017
The effect of pravastatin on bleomycin-induced lung injury and fibrosis in mouse
Source: Annual Congress 2010 - Determinants of acute lung injury and fibrosis
Year: 2010
Rho-kinase inhibitor ameliorates bleomycin-induced chronic lung injury in neonatal rats
Source: Annual Congress 2011 - Issues in paediatric and neonatal intensive care
Year: 2011
Anti-fibrotic effect of telmisartan on bleomycin-induced lung fibrosis in mice
Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies
Year: 2008
PD98059 attenuates the development of bleomycin-induced lung injury and fibrosis
Source: Annual Congress 2010 - Regulation of airway pharmacology
Year: 2010
Dexamethasone inhibits surfactant degradation during bleomycin-induced lung injury in rats
Source: Eur Respir J 2006; 28: Suppl. 50, 855s
Year: 2006
Attenuation by oral N-acetylcysteine of bleomycin-induced lung injury in rats
Source: Eur Respir J 2001; 17: 1228-1235
Year: 2001
Ghrelin ameliorates bleomycin-induced acute lung injury by protecting alveolar epithelial cells and suppressing lung inflammation
Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation
Year: 2012
Metformin attenuates bleomycin-induced pulmonary fibrosis in mice via IGF-1 suppression
Source: International Congress 2018 – Novel insights in the basic and translational research on idiopathic interstitial pneumonias
Year: 2018
Chronic intermittent hypoxia exacerbates lung fibrosis in bleomycin-induced lung injury mouse model
Source: International Congress 2018 – Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities
Year: 2018
Effect of nintedanib on silica-induced lung inflammation and fibrosis in mice
Source: Annual Congress 2012 - Interstitial lung disease: from bench to bedside
Year: 2012
IL-9 protects against bleomycin-induced lethal lung injury through a prostaglandin-dependent mechanism
Source: Eur Respir J 2004; 24: Suppl. 48, 105s
Year: 2004
The effect of curcumin on bleomycin-induced pulmonary fibrosis in rats
Source: Eur Respir J 2006; 28: Suppl. 50, 827s
Year: 2006
Kallistatin protects against LPS-induced mouse lung injury
Source: Annual Congress 2012 - The many roads to lung injury
Year: 2012
Preventive effect of melatonin on bleomycin-induced lung fibrosis in rats
Source: Eur Respir J 2005; 26: Suppl. 49, 82s
Year: 2005
Enhanced lung inflammatory response to intratracheal CpG-ODN in mice with bleomycin-induced lung fibrosis
Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases
Year: 2011
Effect of fasudil on the bleomycin-induced pulmonary fibrosis and hypertension in mice
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms
Year: 2012
Enhanced expression of Robo4 ameliorates LPS-induced acute lung injury in mice
Source: Annual Congress 2011 - Acute respiratory failure
Year: 2011
Treprostinil administration attenuates bleomycin-induced lung fibrosis in mice
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015
Thymosin beta4 protects mice from bleomycin-induced damage in the lung
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept